Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x
Impact News +++ Protokoll des Earnings Call: Hydreight Technologies mit Umsatzsprung in Q3 2025, Aktie unter Druck (Investing.com DE) +++ HYDREIGHT Aktie -26,47%

News zum Sektor Gesundheit aus Asien

Zum Sektor Gesundheit gehören Unternehmen der Pharmaka- & Biotechnologiebranche, Produzenten von medizintechnischen Geräten, Gesundheitsdienste, Kliniken und Pflegeeinrichtungen.
 >Gesundheit ETFs & Fonds 
Es sind 103 ETFs & Fonds zum Sektor Gesundheit bekannt.
 >Aktien zum Sektor Gesundheit 
Es sind 1574 Aktien zum Sektor Gesundheit bekannt.
 
28.11.25 - 22:24
Nobel winner Sakaguchi, Japan′s Shionogi team on cancer treatment (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
28.11.25 - 17:36
Investor Woche: Puma vor Verkauf nach China, BYD verdreifacht Verkäufe in Europa, Novo mit Studienerfolg, Dell erhöht Gewinnprognose, Tesla mit mehr Robotaxis, Jefferies, Wacker Chemie (Verumo)
 
Ifo-Index und US-Verbrauchervertrauen überraschend schwach. Puma vor chinesischer Übernahme. Novo Nordisk meldet Studienerfolg für Gewichtsmedikament, Dell hebt Ausblick an. Tesla will mehr Robotaxis in Austin und BYD verdreifacht Verkäufe in Europa. Merck & Co. Aktie springt nach langer Durststrecke wieder an....
28.11.25 - 09:30
Full-day Takeaway: HSI Closes at 25,858, Down 87 pts; HSTI Closes at 5,599, Up 1 pts; WUXI APPTEC Down over 3%; GAC GROUP, GLOBAL NEW MAT Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI dropped 87 pts or 0.3% to 25,858. HSTI rose 1 pts or 0.0% to 5,599. HSCEI fell 34 pts or 0.4% to 9,130. Market turnover reached $146.20 billion.Active Heavyweights:MEITUAN (03690.HK) closed at $102.5, down 1.4%CCB (00939.HK) closed at $8.17, down 0.7%BABA (09988.HK) closed at $151.5, up 0.6%XIAOMI (01810.HK) closed......
28.11.25 - 07:54
Peter Mandelson′s lobbying firm hired by company linked to Chinese military (The Guardian)
 
Global Counsel signed $3m contract with WuXi AppTec in Europe months after it was named in US national security driveGlobal Counsel, the lobbying firm co-founded by Peter Mandelson, was brought in to advise the Chinese pharmaceutical company WuXi AppTec in Europe months after it was targeted in a US national security crackdown.WuXi AppTec signed a $3m contract with Global Counsel last year to deal with the international fallout from claims that it had links with the Chinese military and was implicated in human rights abuses in Xinjiang. Continue reading......
28.11.25 - 07:30
Eisai Announces Filing Of New Drug Application For Leqembi In Japan (AFX)
 
BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - BioArctic AB's (BIOA-B.ST) partner Eisai (4523.T) announced that they have filed a new drug application for Leqembi or lecanemab for a subcutaneous formulation......
28.11.25 - 06:36
New drug application for subcutaneous formulation of Leqembi[®] submitted in Japan (Cision)
 
Stockholm, Sweden, November 28, 2025 – BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that they have filed a new drug application for Leqembi (lecanemab) for a subcutaneous formulation (subcutaneous autoinjector: SC-AI) as a new route of administration to Japan's Pharmaceuticals and Medical Devices Agency (PMDA). If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the initiation of treatment for this progressive, deadly disease. The application is based on data from multiple subcutaneous (SC)...
28.11.25 - 06:03
Imugene and JW Therapeutics Announce a Collaboration to Advance onCARlytics and Carteyva® Combination in Solid Tumours (PR Newswire)
 
Imugene and JW Therapeutics (Shanghai) Co., LTD have entered a strategic collaboration to evaluate a novel combination therapy using Imugene's onCARlytics (CF33-CD19) oncolytic virus and JW's CD19 CAR-T cell therapy, Carteyva®, in refractory solid tumors. The collaboration includes......
28.11.25 - 05:15
Midday Takeaway: HSI Closes Midday at 25,884, Down 61 pts; HSTI Closes Midday at 5,603, Up 5 pts; WUXI APPTEC Down over 3%; GAC GROUP Hit New Highs (AAStocks)
 
At midday close, HSI dropped 61 pts or 0.2% to 25,884. HSTI rose 5 pts or 0.1% to 5,603. HSCEI fell 20 pts or 0.2% to 9,144.Active Heavyweights:BABA (09988.HK) closed at $151.7, up 0.7%XIAOMI (01810.HK) closed at $40.84, down 0.6%MEITUAN (03690.HK) closed at $103.8, down 0.2%TENCENT (00700.HK) closed at $610.5, down 0.2%HSI & HS......
28.11.25 - 02:57
InnoCare Announces First Patient Dosed in the Global Phase II Clinical Trial of TYK2 Inhibitor Soficitinib for Treatment of Prurigo Nodularis (GlobeNewswire EN)
 
InnoCare's pipeline under development now covers ten major autoimmune diseases, with a particular focus on dermatological conditions....
28.11.25 - 01:33
Eisai Submits New Drug Application for Subcutaneous Formulation of “LEQEMBI®” for the Treatment of Early Alzheimer′s Disease in Japan (GlobeNewswire EN)
 
If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the initiation of treatment for this progressive, relentless disease If approved, lecanemab would be the first and only anti-amyloid treatment in Japan to offer an at-home injection from the initiation of treatment for this progressive, relentless disease...
28.11.25 - 01:00
Roivant (ROIV) Q2 2026 Earnings Call Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
27.11.25 - 09:15
Full-day Takeaway: HSI Closes at 25,945, Up 17 pts; HSTI Closes at 5,598, Down 20 pts; POP MART Up over 6%; HANSOH PHARMA, MTR CORPORATION, LEE & MAN PAPER, GLOBAL NEW MAT, ND PAPER Hit New Highs; Market Turnover Rises (AAStocks)
 
At close, HSI rose 17 pts or 0.1% to 25,945. HSTI dropped 20 pts or 0.4% to 5,598. HSCEI gained 2 pts or 0.0% to 9,164. Market turnover reached $204.73 billion.Active Heavyweights:BABA (09988.HK) closed at $150.6, down 2.7%XIAOMI (01810.HK) closed at $41.1, up 2.5%TENCENT (00700.HK) closed at $611.5, down 1.3%HKEX (00388.HK) clo......
27.11.25 - 06:00
Research: JPM Lists Top Picks for CN Stocks in 1Q26 (Table) (AAStocks)
 
JPMorgan released its Hong Kong stock market outlook report for 2026, listing the top picks for Chinese stocks in 1Q26:SharesBIDU-SW (09888.HK) NTES-S (09999.HK) MIDEA GP (000333.SZ)MIXUE GROUP (02097.HK)Pinduoduo (PDD.US) POP MART (09992.HK) TRIP.COM-S (09961.HK) TINGYI (00322.HK) Futu Holdings (FUTU.US) INNOVENT BIO (01801.HK)......
27.11.25 - 05:30
Results: YIDU TECH Interim Loss Narrows to RMB14.602M (AAStocks)
 
YIDU TECH (02158.HK) has announced its interim results for the period ending September 2025.The company's turnover rose by 8.7% YoY to RMB358 million, while its loss narrowed from RMB43.446 million in the same period last year to RMB14.602 million. No dividend was declared.~AAStocks Financial NewsWeb Site: www.aastocks.com...
27.11.25 - 03:15
H Shrs: HSI Opens Up 17 Pts; ZIJIN MINING Rises 2%+; WUXI APPTEC Recedes 3% (AAStocks)
 
Today (27th) marks the Hong Kong stock market's futures settlement day. The HSI opened up 17 points or 0.07% at 25,945. The HSCEI fell 5 points to 9,156. The HSTECH ebbed 5 points to 5,613.ALI HEALTH (00241.HK) opened flat at HKD6.1. Its adjusted net profit grew 39% in the interim period. XIAOMI-W (01810.HK) edged up 0.3% to......
27.11.25 - 01:15
CSPC feels the pain from sweeping cuts in drug prices (Bamboo Works)
 
The pharmaceutical giant is paying the price for its aggressively low bids in China's centralized drug tenders, as it shifts its focus from traditional to novel drugs Key Takeaway:    By Molly Wen In business as in medicine, a remedy can take time to kick in. This is the challenge for Chinese drug giant CSPC..... The post CSPC feels the pain from sweeping cuts in drug prices appeared first on Bamboo Works....
27.11.25 - 01:03
HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting (GlobeNewswire EN)
 
HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov. 27, 2025 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:​HCM; HKEX:​13) today announces that new and updated data from several studies of compounds discovered by HUTCHMED will be presented at the European Society for Medical Oncology (“ESMO”) Asia Congress 2025, taking place on December 5-7, 2025 in Singapore, and the American Society of Hematology (“ASH”) Annual Meeting taking place on December 6-9, 2025 in Orlando, USA....
26.11.25 - 14:36
GE HealthCare Receives FDA Premarket Authorization For Pristina Recon DL (AFX)
 
WASHINGTON (dpa-AFX) - GE HealthCare Technologies, Inc. (GEHC) announced Wednesday that it has received FDA Premarket Authorization for Pristina Recon DL, an advanced 3D mammography image reconstr......
26.11.25 - 08:24
Japan′s Takeda turns to $1.2bn bet on cancer drugs as patent expirations near (Nikkei)
 
Um den gesamten Artikel unter asia.nikkei.com zu lesen, klicken Sie bitte auf die Überschrift...
25.11.25 - 18:42
Börsenradio Schlussbericht, Di., 25.11.2025: Dummes Wort: Aber es gibt eine "Friedensangst!", DAX Rallye und Eigenkapitalforum (BRN)
 
"Börsenradio to go" meldet sich vom 2. Tag des Eigenkapitalforums der Deutschen Börse: Wir senden O-Töne und Eindrücke direkt aus Frankfurt. An den Märkten sorgt heute "Friedensangst" für Bewegung: Rüstungswerte wie Rheinmetall geraten unter Druck, doch der DAX zieht trotzdem an und schließt mit +1,0 % bei 23.465 Punkten, der EuroStoxx50 steigt auf 5.575 Punkte. Hoffnung auf einen überarbeiteten US-Friedensplan für die Ukraine, ein Goldpreis über 4.100 USD und die weiter laufende KI Rallye bestimmen das Bild. SAP bleibt als Schwergewicht schwach, während Thyssenkrupp Nucera nach enttäuschenden Zahlen und Ausblick abstürzt. An der Wall Street stehen Alphabet und Meta wegen möglicher KI Chipdeals im Fokus, Nvidia gerät unter Druck. Zudem überzeugen Novo Nordisk mit einer Abnehmmittelstudie und Alibaba mit besseren Umsätzen. Was das für die Jahresendrally, für Anlegerstimmung und für einzelne Branchen bedeutet, hören Sie im neuen "Börsenradio to go" Podcast....
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Der Lebenstraum der meisten Österreicher ist, daß sie hinter dem Schreibtisch sitzen und sich an Paragraphen festhalten - das wollen wir ändern. - Dr. Josef Taus
Partner:    >Tradegate Börse | >Dukascopy | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!